Category Archive for: ‘Merck’

Drug Maker to Report Fees to Doctors

This is a step in the right direction. Transparency is needed where conflict may exist in how a doctor, who is a paid consultant to a drug maker, can serve his patients and receive payments from the drug maker simultaneously. This transparency should extend to any relationship between practicing doctors and equipment makers, hospitals, consulting companies and others. Larry Ho, …

Read More

Merck Vioxx Trial Done to Boost Sales, Study Finds

By Elizabeth Lopatto and Michelle Fay Aug. 18 (Bloomberg) — Merck & Co.’s marketing department devised a study on the painkiller Vioxx to persuade 600 doctors involved in the trial to prescribe the drug and recommend it to their peers, researchers say. Their conclusions are based on 100 internal company memos and reports about the study known as Advantage …

Read More

New Experimental Drug Telcagepant Significantly Improves Migraine With Fewer Side Effects

Merck‚Äôs Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study Oral CGRP Receptor Antagonist Provided Similar Migraine Relief with Fewer Adverse Events Compared to Zolmitriptan BOSTON–(BUSINESS WIRE)–Merck & Co., Inc. today announced that, in a Phase III clinical trial, telcagepant (formerly MK-0974), its investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist, significantly improved relief of migraine …

Read More